Armodafinil (Watson Laboratories, Inc.)
Welcome to the PulseAid listing for the Armodafinil drug offered from Watson Laboratories, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Watson Laboratories, Inc. |
NON-PROPRIETARY NAME: | Armodafinil |
SUBSTANCE NAME: | ARMODAFINIL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2012-08-28 |
END MARKETING DATE: | 0000-00-00 |
Armodafinil HUMAN PRESCRIPTION DRUG Details:
Item Description | Armodafinil from Watson Laboratories, Inc. |
LABELER NAME: | Watson Laboratories, Inc. |
DEA SCHEDULE: | CIV
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 2012-08-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0591-3703_a9aa7b52-0cc6-4330-9b91-b723c95eec24 |
PRODUCT NDC: | 0591-3703 |
APPLICATION NUMBER: | ANDA200156 |
Other ARMODAFINIL Pharmaceutical Manufacturers / Labelers: